Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
InnospecIOSP +0.78%76 EV-to-EBIT is 12.80 as of Jul. 25, 2026, which is 15% below its 10-year median of 15.00. GuruFocus rates IOSP with a GF Score™ of 76/100 and a GF Value™ of $95.10 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 1,239 Chemicals companies, Innospec ranks better than 64.65% on this metric.
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Innospec's Enterprise Value for the quarter that ended in Mar. 2026 was $1,574 Mil.
Innospec's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $145 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Innospec EV-to-EBIT Related Terms
Innospec EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Innospec's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Specialty Chemicals subindustry, Innospec's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Innospec EV-to-EBIT vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Innospec's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Innospec's EV-to-EBIT falls into.
Innospec's current Enterprise Value is $1,856 Mil.
Innospec's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $145 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Innospec (IOSP) has a EV-to-EBIT of 12.80 as of Jul. 25, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Innospec and its competitors. This is 15% below median its historical median of 15.00. Over the past decade, Innospec's EV-to-EBIT has ranged from 8.74 to 90.94. According to the industry distribution chart, Innospec ranks #438 out of 1239 companies in the Chemicals industry, placing it in the top 35.4%.
Is Innospec's EV-to-EBIT too high?
Innospec's current EV-to-EBIT of 12.80 is 15% below median its 10-year median of 15.00. Over the past 10 years, this metric has ranged from a low of 8.74 to a high of 90.94. The Chemicals industry median EV-to-EBIT is 17.16. Innospec's value of 12.80 is 25.4% below this industry median. Based on the distribution chart, Innospec ranks #438 out of 1239 companies in the Chemicals industry, which is above the industry midpoint. Overall, Innospec has a GF Score™ of 76/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Innospec's EV-to-EBIT compare to MTX and ODC?
According to the Chemicals industry distribution chart, Innospec ranks #438 out of 1239 companies for EV-to-EBIT. This puts Innospec in the upper half of its industry. The industry median EV-to-EBIT is 17.16. Innospec's value of 12.80 is 25.4% below this benchmark. Historically, Innospec's own EV-to-EBIT has ranged from 8.74 to 90.94 over the past decade. While the company's 10-year median is 15.00 vs. the industry median of 17.16, Innospec has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Chemicals company?
The median EV-to-EBIT among Chemicals companies is 17.16, based on 1,239 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Innospec's current EV-to-EBIT of 12.80 is 25.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Innospec and its competitors. For the Chemicals industry, the median EV-to-EBIT is 17.16 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Innospec's current EV-to-EBIT is 12.80, which is 15% below median its own 10-year median of 15.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Innospec stock overvalued right now?
Based on GuruFocus' analysis, Innospec (IOSP) is currently considered Modestly Undervalued. The stock's GF Value™ is $95.10, compared to a current price of $84.85 — trading 10.8% below its estimated fair value. The current EV-to-EBIT is 12.80, which is 15% below median its 10-year median of 15.00 and 25.4% below the Chemicals industry median of 17.16. Innospec's overall GF Score™ is 76/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Innospec (IOSP), the current EV-to-EBIT is 12.80 as of Jul. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Innospec (IOSP) Overvalued in 2026?
Based on GuruFocus' analysis, Innospec stock appears to be undervalued.
The current stock price of $84.85 is trading 10.8% below its estimated GF Value™ of $95.10.
GuruFocus considers Innospec to be Modestly Undervalued.
Key valuation signals for IOSP:
EV-to-EBIT: 12.80 (15% below median its 10-year median of 15.00)
GF Value™: $95.10 vs. price of $84.85 (10.8% below fair value)
Industry Position: 25.4% below the Chemicals median (#438 of 1239)
No single metric tells the full story. See the IOSP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Innospec Inc manufactures and sells a variety of chemicals and fuel additives. The firm organizes itself into three segments based on product type. The Performance Chemicals segment that derives maximum revenue, provides technology-based solutions for its customers' processes or products in personal care, home care, agrochemical, construction, mining and other industrial markets. The Fuel Specialties segment develops, manufactures, blends, markets and supplies a range of specialty chemical products used as additives in diesel, jet, marine, fuel oil and other fuels. The Oilfield Services segment develops and markets chemical solutions for drilling, completion, production, DRA and oil and gas applications.
76GF Score
Get the complete analysis for IOSP
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IOSP has been successfully added to your 
